Bioadaptives, Inc. (BDPT) Financial Statements (2024 and earlier)

Company Profile

Business Address 2620 REGATTA DRIVE
LAS VEGAS, NV 89128
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments25,44783,1265,03113,0854,96368,006
Cash and cash equivalents 25,40582,9364,58712,3139937,871
Short-term investments421904447724,86430,135
Inventory, net of allowances, customer advances and progress billings8,8774,75013,81511,128  
Inventory8,8774,75013,81511,128  
Prepaid expense  1,000    
Deposits current assets     1,7001,700
Other undisclosed current assets      
Total current assets:34,32488,87618,84624,2136,66369,706
Noncurrent Assets
Property, plant and equipment     5271,055
Intangible assets, net (including goodwill)2,99059,709    
Intangible assets, net (excluding goodwill)2,99059,709    
Total noncurrent assets:2,99059,709  5271,055
TOTAL ASSETS:37,314148,58518,84624,2137,19070,761
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:409,920247,75087,56129,95434,3543,286
Interest and dividends payable    746
Accounts payable6,939   34,3542,540
Accrued liabilities1,01563,100 256  
Other undisclosed accounts payable and accrued liabilities401,966184,65087,56129,698  
Debt381,793403,117405,2367,218  
Derivative instruments and hedges, liabilities686,856557,042827,119   
Due to related parties10,24633,71577,71550,000150,84926,233
Other undisclosed current liabilities   776,91725,36141,359
Total current liabilities:1,488,8151,241,6241,397,631864,089210,56470,878
Noncurrent Liabilities
Total liabilities:1,488,8151,241,6241,397,631864,089210,56470,878
Equity
Equity, attributable to parent, including:(1,451,501)(1,093,039)(1,378,785)(839,876)(203,374)(117)
Common stock25,2555,0822,1591,8941,2751,265
Additional paid in capital6,074,7635,557,8284,225,2173,917,1472,673,1702,623,734
Accumulated other comprehensive loss     (56,675)(31,404)
Accumulated deficit(7,551,679)(6,656,109)(5,606,161)(4,758,917)(2,821,144)(2,593,712)
Other undisclosed equity, attributable to parent160160    
Total equity:(1,451,501)(1,093,039)(1,378,785)(839,876)(203,374)(117)
TOTAL LIABILITIES AND EQUITY:37,314148,58518,84624,2137,19070,761

Income Statement (P&L) (USD)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2015
12/31/2014
Revenues17,17619,77616,3279,934 200
Other income      200
Cost of revenue(10,050)(9,671)(10,232)(5,049)  
Gross profit:7,12610,1056,0954,885 200
Operating expenses(429,026)(646,186)(260,421)(239,292)(227,276)(2,436,425)
Other operating expense, net
(Other Expenses)
  (413,867)(592,918)   
Other undisclosed operating loss      (200)
Operating loss:(421,900)(1,049,948)(847,244)(234,407)(227,276)(2,436,425)
Nonoperating income (expense)(473,670)1,376,219 (4,520)(156)(139,008)
Investment income, nonoperating  90,219 (198,014)  
Gain on sale of leased assets, net, operating leases  1,286,000    
Other nonoperating expense(473,670)     
Interest and debt expense(289,121)(323,394)132,593199,319(156)(746)
Income (loss) from continuing operations before equity method investments, income taxes:(1,184,691)2,877(714,651)(39,608)(227,588)(2,576,179)
Other undisclosed loss from continuing operations before income taxes   (132,593)(199,319)  
Income (loss) from continuing operations before income taxes:(1,184,691)2,877(847,244)(238,927)(227,588)(2,576,179)
Other undisclosed income from continuing operations289,121     
Income (loss) from continuing operations:(895,570)2,877(847,244)(238,927)(227,588)(2,576,179)
Income (loss) before gain (loss) on sale of properties:2,877(847,244)(238,927)(227,588)(2,576,179)
Net income (loss):(895,570)2,877(847,244)(238,927)(227,588)(2,576,179)
Other undisclosed net income (loss) attributable to parent  (1,052,825)  156746
Net loss attributable to parent:(895,570)(1,049,948)(847,244)(238,927)(227,432)(2,575,433)
Preferred stock dividends and other adjustments  193,500    
Net loss available to common stockholders, basic:(895,570)(856,448)(847,244)(238,927)(227,432)(2,575,433)
Interest on convertible debt11,582     
Net loss available to common stockholders, diluted:(883,988)(856,448)(847,244)(238,927)(227,432)(2,575,433)

Comprehensive Income (USD)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2015
12/31/2014
Net income (loss):(895,570)2,877(847,244)(238,927)(227,588)(2,576,179)
Comprehensive income (loss):(895,570)2,877(847,244)(238,927)(227,588)(2,576,179)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent     (25,115)69,342
Comprehensive income (loss), net of tax, attributable to parent:(895,570)2,877(847,244)(238,927)(252,703)(2,506,837)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: